Filters

Glycopyrrolate manufacturers

Filters

3 products found

glycopyrrolate

Vials 0.2 mg/ml - 1 ml, 2 ml, 5 ml, 20 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, China
Comments
Ref: Robinul®
Manufacturer #252

This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

Manufacturer usually replies in 37 days

glycopyrrolate

Injection 0.2 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #37417
A pharmaceutical manufacturer focused on the development, production and distribution of high-quality therapeutic pharmaceutical products, with particular emphasis on sterile injectable medicines alongside other specialty formulations. The company supports partnerships for contract development and manufacturing, aiming to ensure consistent manufacturing practices and reliable supply of its pharmaceutical products to healthcare providers and markets.

Manufacturer usually replies in 2 days

glycopyrrolate

Oral solution 1 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Status: SSPL has successfully developed & established following formulations of glycopyrrolate against RLD Cuvposa. We are in process taking validation batches at our EU-GMP site and soon will be ready with an e-CTD dossier for out-licensing.
Manufacturer #7738
A pharmaceutical manufacturer specialised in both active pharmaceutical ingredients (APIs) and finished dosage pharmaceutical products, with capabilities spanning complex technologies (such as polysaccharides) and advanced intermediate manufacturing. The company’s facilities are certified by major regulatory authorities including US FDA inspection, EU-GMP certification, WHO-GMP certification, plus approvals from COFEPRIS (Mexico) and the Korean MFDS, supporting global supply to multiple regions worldwide.

Manufacturer usually replies in 6 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.